Pemphigus herpetiformis – A case report of a rare form of pemphigus and review of the literature
Abstract
Introduction. Pemphigus herpetiformis is the rare variant of pemphigus with characteristic clinical features, histopathological findings different from the convectional pemphigus, and immunological findings consistent with pemphigus. Case report. We presented a 65-year-old woman with initial pruritus followed by pruritic urticarial papules and plaques, some with annular rings of tense vesicles on the periphery, on the trunk and extremities, with no mucous lesions. Histopathological examination demonstrated spongiosis and intraepidermal vesicles in the mid or subcorneal epidermis in some biopsy specimen, with neutrophil and eosinophil infiltrate. Direct immunoflorescent microscopy revealed intercellular IgG deposition, most prominent in the upper layers of epidermis. Indirect immunoflorescent microscopy showed intercellular binding of IgG autoantibodies in the patient’s sera. Initially the patient was threated with systemic corticosteroids and azathioprine, but dapson provided complete clinical remission. Conclusion. This entity was established 40 years ago, and around 100 patients have been reported worldwide. It is important to be aware of this particular form of pemphigus because clinical presentation, course of the disease and therapeutic approach are different from conventional forms of pemphigus.
References
Payne S, Stanley R. Pemphigus. In: Goldsmith LA, Katz SI, Gil-chrest BA, Paller AS, Leffell DJ, Wolff K, et al, editors. Fitzpatrick's dermatology in general medicine, 8th ed. New York: McGraw Hill; 2012. p. 586−99.
Hertl M, Jedlickova H, Karpati S, Marinovic B, Uzun S, Yayli S, et al. Pemphigus. S2 Guidelines for diagnosis and treatment-guided by Europian Dermatology Forum (EDF) in coopera-tion with the Europian Academy of Dermatologuy and Ve-nereology (EADV). J Eur Acad Dermatol Venereol 2015; 29(3): 405−14.
Radoš J. Autoimmune blistering diseases: Histologic meaning. Clin Dermatol 2011; 29(4): 377−88.
Amagai M. Pemphigus. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, editors. Dermatology. 2nd ed. London: Elsevier Limited; 2008. p. 417−29.
Porro M, Caetano V, Maehara S, Enokihara M. Non-classical forms of pemphigus: Pemphigus herpetiformis, IgA pemphi-gus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol 2014; 89(1): 96−106.
Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: Clinical manifestatuions. J Dtsch Dermatol Ges 2011; 9(10): 844−56.
Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 1975; 14(5): 353−9. 14(5): 353−9.
Leithauser A, Mutasim F. A Case of Pemphigus Herpetiformis Occurring in a 9- Year-Old Boy. Pediatr Dermatol 2013; 30(6): 760−2.
Moutran R, Maatouk I, Stephan F, Halaby E, Abadjian G, Tomb R. Letter: Pemphigus herpetiformis of age of onset at 6 years. Dermatol Online J 2011; 17(6): 10.
Kasperkiewicz M, Kowalewski C, Jabłońska S. Pemphigus herpeti-formis: From first description until now. J Am Acad Dermatol 2014; 70(4): 780−7.
Duarte B, Bastazini I, Barreto A, Carvalho V, Nunes J. Pemphigus herpetifomis in childhood. Pediatr Dermatol 2010; 27(5): 488−91.
Hocar O, Ait SI, Akhdari N, Hakkou M, Amal S. A case of pemphigus herpetiformis in a 12-year-old male. ISRN Pediatr 2011; 2011: 712560.
Floden CH, Gentele H. A case of clinically typical dermatitis her-petiformis (MB Duhring) presenting acantholysis. Acta Derm Venereol 1955;5(2): 128−31.
Laws M, Heelan K, Al-Mohammedi F, Walsh S, Shear H. Pemphi-gus herpetiformis: A case series and review of the literature. Int J Dermatol 2015; 54(9): 1014−22.
Lebeau S, Muller R, Masouye I, Hertl M, Borradori L. Pemphigus herpetiformis: Analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. Clin Exp Dermatol 2010; 35(4): 366−72.
Santi G, Maruta W, Aoki V, Sotto N, Rivitti A, Diaz A. Pemphi-gus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus, fogo selvgem, and pemphigus vulgaris. Cooperative Group on Fogo Selvagem Research. J Am Acad Dermatol 1996; 34(1): 40−6.
Fuentes-Finkelstein P, Barnadas M, Gelpi C, Puig L. Pemphigus herpetiformis with progression to pemphigus foliaceus: A case report. Actas Dermosifiliogr 2014; 105(5): 526−8. (Spanish, English)
O'Toole EA, Mak LL, Guitart J, Woodley DT, Hashimoto T, Ama-gai M, et al. Induction of keratinocyte IL-8 expression and se-cretion by IgG autoantibodies as a novel mechanism of epi-dermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol 2000; 119(1): 217−24.
Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pem-phigus variants. J Am Acad Dermatol 1999; 40(5 Pt 1): 649−71; quiz 672−3.
Ohata C, Koga H, Teye K, Ishii N, Hamada T, Dainichi T, et al. Concurrence of bullous pemphigoid and herpetiform pemphigus with IgG antibodies to desmogleins 1/3 and desmocollins 1-3. Br J Dermatol 2013; 168(4): 879−81.
Ohyama B, Nishifuji K, Chan PT, Kawaguchi A, Yamashita T, Ishii N, et al. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules. J Invest Dermatol 2012; 132(4): 1158−68.
Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: Lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110(2): 103−9.
Palleschi M, Giomi B. Herpetiformis pemphigus and lung carci-noma: A case of paraneoplastic pemphigus. Acta Derm Ve-nereol 2002; 82(4): 304−5.
Prado R, Brice L, Fukuda S, Hashimoto T, Fujita M. Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions. Arch Dermatol 2011; 147(1): 67−71.
Kozlowska A, Hashimoto T, Jarzabek-Chorzelska M, Amagai A, Nagata Y, Strasz Z, et al. Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Acad Dermatol 2003; 48(1): 117−22.
Matsukura S, Takahashi K, Hirokado M, Ikezawa Y, Nakamura K, Fukuda K, et al. Recalcitrant pemphigus herpetiformis with high titer of immunoglobulin G antibody to desmoglein 1 and positive IgG antibody to desmocollin 3, elevating thymus and activation-regulated chemokine. Int J Dermatol 2014; 53(8): 1023−6.
Tateishi C, Tsuruta D, Nakanishi T, Uehara S, Kobayashi H, Ishii M, et al. Antidesmocollin-1 antibody-positive, antidesmoglein antibody-negative pemphigus herpetiformis. J Am Acad Der-matol 2010; 63(1): e8−10.
Yamamoto M, Ikai K, Horiguchi Y. A case of herpetiform pem-phigus associated with lung cancer. Acta Dermatol (Kyoto) 1988; 83: 63−7.
Vicente MA, Iranzo P, Castell T, Baradad M, Palou J, Mascaro JM. Pemphigus herpetiformis associated with neoplasm of the lung. Med Cutan Ibero Lat Am 1989; 17(6): 373−8.
Kubota Y, Yoshino Y, Mizoguchi M. A case of herpetiform pem-phigus associated with lung cancer. J Dermatol 1994; 21(8): 609−11.
Arranz D, Corral M, Prats I, Lopez-Ayala E, Castillo C, Vidaurra-zaga C, et al. Herpetiform pemphigus associated with esopha-geal carcinoma. Actas Dermosifiliogr 2005; 96(2): 119−21. (Spanish)
Marzano AV, Tourlaki A, Cozzani E, Gianotti R, Caputo R. Pemphigus herpetiformis associated with prostate cancer. J Eur Acad Dermatol Venereol 2007; 21(5): 696−8.
Lu Y, Zhang M. Pemphigus herpetiformis in a patient with well-differentiated cutaneous angiosarcoma: Case report and review of the published work. J Dermatol 2012; 39(1): 89−91.
Shimizu K, Hashimoto T, Wang N, Watanabe K, Ohata Y, Kikuchi A, et al. A case of herpetiform pemphigus associated with au-toimmune hemolytic anemia: Detection of autoantibodies against multiple epidermal antigens. Dermatology 1996; 192(2): 179−82.
Morita E, Amagai M, Tanaka T, Horiuchi K, Yamamoto S. A case of herpetiform pemphigus coexisting with psoriasis vulgaris. Br J Dermatol 1999; 141(4): 754−5.
Sanchez-Palacios C, Chan LS. Development of pemphigus her-petiformis in a patient with psoriasis receiving UV-light treat-ment. J Cutan Pathol 2004; 31(4): 346−9.
Marinović B, Basta-Juzbasić A, Bukvić-Mokos Z, Leović R, Loncarić D. Coexistence of pemphigus herpetiformis and systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2003; 17(3): 316−9.
Bull RH, Fallowfield ME, Marsden RA. Autoimmune blistering diseases associated with HIV infection. Clin Exp Dermatol 1994; 19(1): 47−50.
Marsden RA, Dawber RP, Millard PR, Mowat AG. Herpetiform pemphigus induced by penicillamine. Br J Dermatol 1977; 97(4): 451−2.
Weltfriend S, Ingber A, David M, Sandbank M. Pemphigus herpe-tiformis following D-penicillamine in a patient with HLA B8. Hautarzt 1988; 39(9): 587−8. (German)
Verdier-Sevrain S, Joly P, Thomine E, Belanyi P, Gilbert D, Tron F, et al. Thiopronine-induced herpetiform pemphigus: Report of a case studied by immunoelectron microscopy and immunoblot analysis. Br J Dermatol 1994; 130(2): 238−40.
Maciejowska E, Jablonska S, Chorzelski T. Is pemphigus herpeti-formis an entity. Int J Dermatol 1987; 26(9): 571−7.
Seitz CS, Staegemeir E, Amagai M, Rose C, Bröcker EB, Zillikens D. Pemphigus herpetiformis with an autoimmune response to recombinant desmoglein 1. Br J Dermatol 1999; 141(2): 354−5.
Ingber A, Feuerman EJ. Pemphigus with characteristics of der-matitis herpetiformis. Int J Dermatol 1986; 25(9): 575−9.
Durham A, Carlos CA, Gudjonsson JE, Lowe L, Hristov AC. Pem-phigus herpetiformis: report of a rare case. J Am Acad Dermatol 2012; 67(5): e231−3.
Wosnitza M, Blazek C, Megahed M. Pemphigus herpetiformis. Hautarzt 2008; 59(6): 459−60. (German)
Wu C, Zuo Y, Jin H, Chen J, Li L. Treatment of pemphigus herpetiformis with minocycline and nicotinamide. Chin Med J (Engl) 2014; 127: 3514.